About MBQ Pharma
mbq-pharma targets rac and cdc42 as key targets for tumor growth inhibition and removal of pre-existing metastasis. mbq-167 is a first-in-class nanomolar ic50 inhibitor for rac and c... Read more
mbq-pharma targets rac and cdc42 as key targets for tumor growth inhibition and removal of pre-existing metastasis. mbq-167 is a first-in-class nanomolar ic50 inhibitor for rac and c... Read more